Pubblicazioni

Modulating undruggable targets to overcome cancer therapy resistance

2022 - DRUG RESISTANCE UPDATES

Passirani, C.; Vessieres, A.; La Regina, G.; Link, W.; Silvestri, R.

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

2021 - FRONTIERS IN IMMUNOLOGY

D'Amico, Silvia; D'Alicandro, Valerio; Compagnone, Mirco; Tempora, Patrizia; Guida, Giusy; Romania, Paolo; Lucarini, Valeria; Melaiu, Ombretta; Falco, Michela; Algeri, Mattia; Pende, Daniela; Cifaldi, Loredana; Fruci, Doriana

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

2021 - FRONTIERS IN IMMUNOLOGY

Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences

2019 - JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Cirone, M.; Gilardini Montani, M. S.; Granato, M.; Garufi, A.; Faggioni, A.; D'Orazi, G.